{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:59:18Z","timestamp":1794268758301,"version":"4.9.0"},"reference-count":50,"publisher":"BMJ","issue":"3","funder":[{"name":"Region Stockholm","award":["postdoctural appointment"],"award-info":[{"award-number":["postdoctural appointment"]}]},{"name":"NIH","award":["K23 DK122104"],"award-info":[{"award-number":["K23 DK122104"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Gut"],"accepted":{"date-parts":[[2022,7,18]]},"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Longitudinal evidence is lacking regarding the long-term risk of major adverse cardiovascular events (MACE) in children and young adults with non-alcoholic fatty liver disease (NAFLD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This nationwide cohort study included all Swedish children and young adults \u226425 years old with histologically confirmed NAFLD and without underlying cardiovascular disease (CVD) at baseline (1966\u20132016; n=699). NAFLD was defined from prospectively recorded histopathology, and further categorised as simple steatosis or non-alcoholic steatohepatitis (NASH). NAFLD patients were matched to \u22645 population controls without NAFLD or CVD (n=3353). Using Cox proportional hazards modelling, we calculated multivariable-adjusted HRs (aHRs) and 95% CIs for incident MACE (ie, ischaemic heart disease, stroke, congestive heart failure or cardiovascular mortality). In secondary analyses, we also explored rates of incident cardiac arrhythmias.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Over a median follow-up of 16.6 years, incident MACE was confirmed in 33 NAFLD patients and 52 controls. NAFLD patients had significantly higher rates of MACE than controls (3.1 vs 0.9\/1000 person-years (PY); difference=2.1\/1000 PY; aHR=2.33, 95% CI=1.43 to 3.78), including higher rates of ischaemic heart disease (difference=1.4\/1000 PY; aHR=3.07, 95% CI 1.62 to 5.83) and congestive heart failure (difference=0.5\/1000 PY; aHR=3.89, 95% CI=1.20 to 12.64). Rates of incident MACE outcomes appeared to be further augmented with NASH (aHR=5.27, 95% CI=1.96 to 14.19). In secondary analyses, NAFLD patients also had significantly higher rates of cardiac arrythmias (aHR=3.16, 95% CI=1.49 to 6.68).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Compared with matched population controls, children and young adults with biopsy-proven NAFLD had significantly higher rates of incident MACE, including ischaemic heart disease and congestive heart failure. Research to better characterise cardiovascular risk in children and young adults with NAFLD should be prioritised.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/gutjnl-2022-328105","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T13:21:36Z","timestamp":1671110496000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease"],"prefix":"10.1136","volume":"72","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0610-5287","authenticated-orcid":false,"given":"Tracey G","family":"Simon","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Roelstraete","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim","family":"Alkhouri","sequence":"additional","affiliation":[{"name":"Hepatology, Arizona Liver Health, Chandler, Arizona, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8474-1759","authenticated-orcid":false,"given":"Hannes","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Sweden"},{"name":"Division of Hepatology, Department of Upper GI Diseases, Karolinska Hospital, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Uppsala University, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas F","family":"Ludvigsson","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden"},{"name":"Department of Pediatrics, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"key":"2025090800142339000_72.3.573.1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2017.109"},{"key":"2025090800142339000_72.3.573.2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0140908"},{"key":"2025090800142339000_72.3.573.3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20842"},{"key":"2025090800142339000_72.3.573.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.07.027"},{"key":"2025090800142339000_72.3.573.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.02.045"},{"key":"2025090800142339000_72.3.573.6","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32833a7de6"},{"key":"2025090800142339000_72.3.573.7","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/oby.21879","article-title":"Nonalcoholic steatohepatitis is associated with cardiac remodeling and dysfunction","volume":"25","author":"Simon","year":"2017","journal-title":"Obesity"},{"key":"2025090800142339000_72.3.573.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.05.013"},{"key":"2025090800142339000_72.3.573.9","doi-asserted-by":"crossref","first-page":"101215","DOI":"10.1016\/j.diabet.2020.101215","article-title":"Nafld, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment","volume":"47","author":"Targher","year":"2021","journal-title":"Diabetes Metab"},{"key":"2025090800142339000_72.3.573.10","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29367"},{"key":"2025090800142339000_72.3.573.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.11.004"},{"key":"2025090800142339000_72.3.573.12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.08.050"},{"key":"2025090800142339000_72.3.573.13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2017.02.030","article-title":"In children with nonalcoholic fatty liver disease, zone 1 steatosis is associated with advanced fibrosis","volume":"16","author":"Africa","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090800142339000_72.3.573.14","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28374"},{"key":"2025090800142339000_72.3.573.15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.520"},{"key":"2025090800142339000_72.3.573.16","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-1212"},{"key":"2025090800142339000_72.3.573.17","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-198406000-00018"},{"key":"2025090800142339000_72.3.573.18","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12694"},{"key":"2025090800142339000_72.3.573.19","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.jhep.2021.06.034","article-title":"Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality","volume":"75","author":"Simon","year":"2021","journal-title":"J Hepatol"},{"key":"2025090800142339000_72.3.573.20","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S191914"},{"key":"2025090800142339000_72.3.573.21","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325724"},{"key":"2025090800142339000_72.3.573.22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MPG.0000000000001482","article-title":"NASPGHAN clinical practice guideline for the diagnosis and treatment of nonalcoholic fatty liver disease in children: recommendations from the expert Committee on NAFLD (ECON) and the North American Society of pediatric gastroenterology, hepatology and nutrition (NASPGHAN)","volume":"64","author":"Vos","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090800142339000_72.3.573.23","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/j.gastro.2020.01.048","article-title":"Nonalcoholic fatty liver disease in children: unique considerations and challenges","volume":"158","author":"Goldner","year":"2020","journal-title":"Gastroenterology"},{"key":"2025090800142339000_72.3.573.24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23133"},{"key":"2025090800142339000_72.3.573.25","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0117-y"},{"key":"2025090800142339000_72.3.573.26","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"2025090800142339000_72.3.573.27","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-11-450"},{"key":"2025090800142339000_72.3.573.28","first-page":"603","article-title":"[Reliability of the hospital registry. The diagnostic data are better than their reputation]","volume":"91","author":"Nilsson","year":"1994","journal-title":"Lakartidningen"},{"key":"2025090800142339000_72.3.573.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(00)00366-1"},{"key":"2025090800142339000_72.3.573.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2004.12.007"},{"key":"2025090800142339000_72.3.573.31","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-017-0316-1"},{"key":"2025090800142339000_72.3.573.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-019-00511-8"},{"key":"2025090800142339000_72.3.573.33","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1294"},{"key":"2025090800142339000_72.3.573.34","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.017719"},{"key":"2025090800142339000_72.3.573.35","doi-asserted-by":"crossref","DOI":"10.1186\/s12872-020-01737-1","article-title":"Validation of myocardial infarction diagnosis in patients with congenital heart disease in Sweden","volume":"20","author":"Fedchenko","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2025090800142339000_72.3.573.36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2468-1253(21)00308-3","article-title":"Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis","volume":"6","author":"Mantovani","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2025090800142339000_72.3.573.37","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00604.2005"},{"key":"2025090800142339000_72.3.573.38","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-320622"},{"key":"2025090800142339000_72.3.573.39","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318811"},{"key":"2025090800142339000_72.3.573.40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/s41591-019-0379-5","article-title":"Platelet GPIb\u03b1 is a mediator and potential interventional target for NASH and subsequent liver cancer","volume":"25","author":"Malehmir","year":"2019","journal-title":"Nat Med"},{"key":"2025090800142339000_72.3.573.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.03.013"},{"key":"2025090800142339000_72.3.573.42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"Il-1 family cytokine pathways underlying NAFLD: towards new treatment strategies","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med"},{"key":"2025090800142339000_72.3.573.43","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1038\/oby.2008.64","article-title":"Nash predicts plasma inflammatory biomarkers independently of visceral fat in men","volume":"16","author":"Targher","year":"2008","journal-title":"Obesity"},{"key":"2025090800142339000_72.3.573.44","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2018.06.031","article-title":"Bioactive lipid species and metabolic pathways in progression and resolution of nonalcoholic steatohepatitis","volume":"155","author":"Musso","year":"2018","journal-title":"Gastroenterology"},{"key":"2025090800142339000_72.3.573.45","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx342"},{"key":"2025090800142339000_72.3.573.46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061803"},{"key":"2025090800142339000_72.3.573.47","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1089\/met.2016.0132","article-title":"The influence of epicardial fat and nonalcoholic fatty liver disease on heart rate recovery in metabolic syndrome","volume":"15","author":"Cho","year":"2017","journal-title":"Metab Syndr Relat Disord"},{"key":"2025090800142339000_72.3.573.48","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2019.01.035","article-title":"The degree of hepatic steatosis associates with impaired cardiac and autonomic function","volume":"70","author":"Houghton","year":"2019","journal-title":"J Hepatol"},{"key":"2025090800142339000_72.3.573.49","doi-asserted-by":"publisher","DOI":"10.1177\/0161734615595015"},{"key":"2025090800142339000_72.3.573.50","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2008.171280"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gutjnl-2022-328105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:14:36Z","timestamp":1757315676000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gutjnl-2022-328105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2,7]]},"published-print":{"date-parts":[[2023,3]]}},"alternative-id":["10.1136\/gutjnl-2022-328105"],"URL":"https:\/\/doi.org\/10.1136\/gutjnl-2022-328105","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]}}}